l General Information |
Product Name | Salirasib |
General description | Salirasib is a potent competitive prenylated protein methyltransferase (PPMTase) inhibitor. |
Synonym | 2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylbenzoic acid; Farnesylthiosalicylic acid; FTS |
Purity | ≥98.5%(HPLC) | CAS Number | 162520-00-5 |
Formula | C22H30O2S | Molecular Weight | 358.54 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
l Biological Information |
Biochem/Physiol Actions | Salirasib is a potent competitive prenylated protein methyltransferase (PPMTase) inhibitor (Ki = 2.6μM), which inhibits Ras methylation. |
l Packaging & Storage |
Packaging | 5mg; 10mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |